← All trials
NCT04110678
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2015
- Primary completion
- Feb 11, 2016
- Completion date
- Jan 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 26
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- International Center for Neurological Restoration, CubaLead sponsor
- University of Electronic Science and Technology of ChinaCollaborator
- International Center for Neurological Restoration, CubaReponsible party - principal investigator
- Centro Nacional Producción Animales de Laboratorio (CENPALAB)Overall official - principal investigator
- Centro Inmunologia Molecular (CIM)Overall official - principal investigator
- Centro Inmunologia Molecular (CIM)Study chair
- Centro Inmunologia Molecular (CIM)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.